search-icon
        bookmark-img bookmark-img
        Jan 30 2020

        (VIDEO) Voice of the Customer: Platelet BioGenesis

        Picture of ZAGENO Team
        By ZAGENO Team

        As the world leader in making platelets, Platelet BioGenesis sees a future where minor disruptions, natural disasters, and major emergencies do not generate urgent calls for blood donations, and where doctors have a new tool to treat diseases that do not respond to current therapies. From the beginning, ZAGENO and Platelet BioGenesis have worked in partnership for the development of future automation tools to protect time for science.

        From its facilities, in the heart of the life sciences hub of Boston-Cambridge, Massachusetts, in the United States, key members of the Platelet BioGenesis team sat down to discuss some of its key challenges. Excerpts from those discussions appear in the video, below.

         

        Length 4:08 (short version, below)

        Among its many goals is to safeguard the time of its scientists through automating processes across its business. A culprit that had diminished time for science was the procurement of its lab supplies.

        Prior to ZAGENO, the team at Platelet BioGenesis had no other choice than to comb hundreds of web sites, spending between 2-3 hours a day just to manage lab supplies. Now, with ZAGENO, that same process has significantly improved. Today, Platelet BioGenesis benefits from ZAGENO’s marketplace of more than 11 million products from approximately 3,500 suppliers. Regardless of the number of supplier brands or products in its order, Platelet BioGenesis receives just one invoice, saving time for its back-office team as well. 

        .  .  .

        Video Transcript

        My name is Lea Beaulieu. I'm an associate director, first hire at Platelet BioGenesis.

        My role is a unique one. I do a lot of operations - science operations and a little bit of the business operations. It's really important to keep people focused, especially as a startup. We have very tight timelines. We have deliverables that we really need to bring in. You have different funding sources as a startup in private, but you also have grants. You really need people to be focused on what they're doing. And so anything that we can have that would help make things easier, make just a simple process easier, is key, it's huge.

        Anything that we can have that would help make things easier, make just a simple process easier, is key, it's huge.

        And then also making sure we have an element of communication, so everyone's talking, everyone's keeping updated. Previously, everything was online. We'd have to go to each individual company, knowing multiple passwords, making sure, okay well this company, you have to order it this way, but this company, I've got to order it this way. And this company, I actually have to call them. I had done that in my previous job, and when we started here ordering specifically from every single company. And we'd have a simple platform that we can just go to one place, put it everything we need and explain how this gets divided out based on groups and departments, and it's just going to save us a lot of time. Ordering used to take... You could do it two, three hours a day, and you would still not really get very far, especially now with the size we are.

        Ordering used to take (...) two, three hours a day, and you would still not really get very far, especially now with the size we are.

        I am Ryan Chappell. I'm the operations manager here at Platelet BioGenesis.

        ZAGENO will say right away, "There's a back order notification," so that we can pivot and can say, "All right, what else can we buy to get us through in the meantime? Who do I need to talk to? Who do I need to reach out to, to see if there's any way we can track down these reagents and not compromise our productivity?"

        ZAGENO will say right away, 'There's a back order notification' so that we can pivot and we can say, 'All right, what else can we buy to get us through in the meantime? Who do I need to talk to? Who do I need to reach out to, to see if there's any way we can track down these reagents and not compromise our productivity?"

        Another aspect was just the fact that we did have those hundred accounts, and balancing between them, and trying to record all of the different account information is a huge waste of time when there's something like one consolidated marketplace. I think one of the benefits of working with ZAGENO that I can't overstate, is the fact that we were this young, young company when I first came across ZAGENO.

        ZAGENO actually approached us and said, "Hey, we're trying to build something. Are you willing to work with us?" And we have grown up as companies together, and there has been this constant conversation. I would not underestimate the value of a platform that offers you flexibility, that you can say, "I need this feature." And then a week later, you now have that feature. They've built it in to the product.

        We needed something that would grow with us because we often don't know what our company's going to look like six months from now. Maybe we were going in a different direction. Maybe we have a different source of cells or different team structures. And we needed a platform that would allow us to change things constantly, and ZAGENO has. And that adaptability is probably the main driving force for why it's been so helpful and why we're still using it every day to this day.

        We needed a platform that would allow us to change things constantly, and ZAGENO has. And that adaptability is probably the main driving force for why it's been so helpful and why we're still using it every day to this day.

        .  .  .

         

        Get answers to your questions, and find     

        why ZAGENO is the best choice for you

         

        Schedule a Demo

         

        .  .  .

        Short version: length 1:26

        Platelet_BioGenesis_RYAN_v1.3

         

        .  .  .

         

        Platelet BioGenesis (PBG) has created the only platform that can generate human platelets at scale. The stem cell-derived, on-demand platelets will be the first donor-independent source of platelets to address the chronic shortage worldwide. The company is also developing genetically engineered platelet-based therapeutics, a new treatment modality for cancer and other life-threatening diseases. PBG’s platform is patented and cGMP-compliant. Learn more at plateletbiogenesis.com.

         

        Topics: new features, customer, purchasing, Automation, scientist, biotech

        Get our latest posts and more in our weekly newsletter

        Comment & engage with our ZAGENO community